Comparison of two immunoassays for the measurement of serum HE4 for ovarian cancer
Introduction: The use of Human Epididymis Protein 4 (HE4) as a biomarker for ovarian cancer is gaining traction, providing the impetus for development of a high throughput automated HE4 assay that is comparable to the conventional manual enzyme immunometric-assay (EIA). The aim of this study was to...
Main Authors: | Barr, C.E (Author), Crosbie, E.J (Author), Funston, G. (Author), Howe, J.D (Author), Mounce, L.T.A (Author), Pemberton, P.W (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier B.V.
2021
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Comparison of two immunoassays for the measurement of serum HE4 for ovarian cancer
by: Chloe E. Barr, et al.
Published: (2021-08-01) -
Current advances in immunoassays for the detection of antibiotics residues: a review
by: Saeed Ahmed, et al.
Published: (2020-01-01) -
Comparison of the performance of three cancer antigen (CA) 15-3 immunoassays
by: Nafija Serdarevic, et al.
Published: (2016-12-01) -
Development of a chemiluminescent enzyme immunoassay to detect cadmium in cereal samples
by: Zhi-Li Xiao, et al.
Published: (2018-01-01) -
A sensitive chemiluminescence based immunoassay for the detection of cortisol and cortisone as stress biomarkers
by: Jwan O. Abdulsattar, et al.
Published: (2019-12-01)